Article

Eye Center at UC Davis Health receives $4 million donation to support glaucoma research and treatment

Author(s):

The Eye Center at UC Davis Health has two new endowed chairs focused on glaucoma, thanks to a $4 million donation from business entrepreneur Daryl Geweke.

The Eye Center at UC Davis Health. (Image courtesy of UC Davis)

The Eye Center at UC Davis Health. (Image courtesy of UC Davis)

The Eye Center at UC Davis Health has two new endowed chairs focused on glaucoma, thanks to a $4 million donation from local business entrepreneur Daryl Geweke.

According to a UC Davis news release, James D. Brandt, MD, and Nicholas R. Marsh-Armstrong, PhD, are the inaugural holders of the new endowed chairs. Their investitures were celebrated at a ceremony last month.

”This incredibly generous gift from Mr. Geweke will serve as a catalyst to advance the understanding and treatment of glaucoma for generations to come. The inaugural chair holders represent great talent in both the unraveling of the causes of glaucoma as well as newer methods of treatment now and in the future,” said Mark J. Mannis, MD, FACS, professor and chair of the Department of Ophthalmology & Vision Science. “It is an investment that will pay dividends to the people of our nation and the world for many years. We cannot thank Mr. Geweke enough.”

According to the university news release, Geweke opened his first auto dealership in Lodi, California, in 1966 — Geweke Ford. Over the next several decades, he went on to own Geweke Toyota, Dodge, Chrysler, Jeep, Kia and an RV dealership. His business later grew to include hotels, a convenience store, a car wash, and an office and retail building. Geweke’s wife of 68 years, Opal, named in the endowed chairs, passed away in 2018.

With this gift, Geweke joins other lead donors to the university’s $2 billion comprehensive fundraising campaign, “Expect Greater: From UC Davis, for the world,” the largest philanthropic endeavor in university history. Together, donors and UC Davis are advancing work to prepare future leaders, sustain healthier communities, and bring innovative solutions to today's most urgent challenges.

Support for glaucoma research and treatment

Brandt, the inaugural holder of the Daryl and Opal Geweke Endowed Chair in Glaucoma, treats glaucoma, particularly in children. He strongly believes that an informed patient is an empowered patient.

James D. Brandt, MD

James D. Brandt, MD

Brandt considers partnering with parents and watching their kids grow up one of the most important (and fun) things he does. As a volunteer with Orbis International, a non-profit, non-governmental organization dedicated to saving sight worldwide, Brandt has traveled to more than a dozen developing countries to care for children with glaucoma and to teach surgical techniques to local surgeons.

Nicholas R. Marsh-Armstrong, PhD

Nicholas R. Marsh-Armstrong, PhD

Marsh-Armstrongthe inaugural chairholder of the Daryl and Opal Geweke Endowed Chair in Glaucoma Research, studies basic science questions related to glaucoma. His lab focuses on three main areas of research.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
© 2025 MJH Life Sciences

All rights reserved.